UPDATE : Monday, September 7, 2020
상단여백
Regulator to consider re-classifying choline alfoscerate as functional food
The Ministry of Food and Drug Safety has requested drugmakers to submit eff...
by Kim Yun-mi  |  2019-11-06 13:54
라인
Merck Korea hurries to close GM part despite union’s protest
Merck Biopharma Korea is stepping up the closure of general medicine (GM) d...
by Kim Yun-mi  |  2019-11-05 15:04
라인
Takeda Korea fires union leader to worsen labor-management dispute
Takeda Pharmaceutical Korea dismissed Kim Young-buk, the leader of Korea De...
by Kim Yun-mi  |  2019-11-04 15:03
라인
Hanyang University Medical Center goes research-centered
“If a hospital focuses only on patient care, it has little chance to grow. ...
by Kim Yun-mi  |  2019-11-01 16:09
라인
Huons’ insomnia cure, 2 other drugs to win insurance benefit
The Ministry of Health and Welfare said it would grant health insurance ben...
by Kim Yun-mi  |  2019-10-31 13:22
라인
AbbVie’s new psoriasis drug likely to win nod this year
AbbVie’s new psoriasis treatment Risankizumab is likely to obtain local lic...
by Kim Yun-mi  |  2019-10-30 16:05
라인
Scope of AI-based medical devices expanded for licensing review
The Ministry of Food and Drug Safety said it would expand the scope of arti...
by Kim Yun-mi  |  2019-10-30 16:03
라인
[Special] Yongin Severance Hospital to go digital with innovation
This is an artist’s rendition of the newly built Yongin Severance Hospital,...
by Kim Yun-mi  |  2019-10-28 15:45
라인
‘Korean hospitals equipped well to use CAR-T therapy’
“CAR-T (chimeric antigen receptor T-cell) therapy has dramatically improved...
by Kim Yun-mi  |  2019-10-23 13:17
라인
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent
Pfizer recently proved the efficacy of its investigational atopic dermatiti...
by Kim Yun-mi  |  2019-10-22 14:17
라인
Merck Korea forcefully shuts down general medicine biz
Merck Biopharma Korea said it would complete shutting down the General Medi...
by Kim Yun-mi  |  2019-10-15 15:51
라인
Galderma Korea’s key strategy: choice and concentration
Galderma recently debuted as the world’s largest independent dermatology co...
by Kim Yun-mi  |  2019-10-15 13:56
라인
[Special] How are Korean employees coping with big-pharma M&As?
Since multinational pharmaceutical companies announced merger and acquisiti...
by Kim Yun-mi  |  2019-10-14 13:45
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
Sanofi said it would run a program to support part of the cost of Dupixent,...
by Kim Yun-mi  |  2019-10-11 15:13
라인
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’
The medical community criticized Boehringer Ingelheim Korea’s recent releas...
by Kim Yun-mi  |  2019-10-10 16:01
라인
Medtronic Korea denies regulatory negligence over recalled insulin pumps
A group of diabetic patients criticized the local regulator for inadequate ...
by Kim Yun-mi  |  2019-10-08 15:05
라인
Galderma Korea workers feel insecure after separation from Nestle
Galderma has debuted as a rebranded dermatology company after separation fr...
by Kim Yun-mi  |  2019-10-07 14:38
라인
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi  |  2019-10-02 16:03
라인
‘Merck Korea unilaterally lays off employees’
Merck Biopharma Korea has been embroiled in a labor dispute.Merck Korea bra...
by Kim Yun-mi  |  2019-10-01 11:09
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi  |  2019-09-26 11:26
여백
여백
여백
Back to Top